Hot and Ready
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On the PBD podcast Dr James Abramson, who teaches at Harvard Medical School, says Peer reviewers don't have all the data, they just have some of the data given to them by Anavex, NOT ALL THE DATA. YouTube Patrick Bet David- Dr. James Abramson. The Reviewers submit to the Journals. Feel Free to check it out. Is the issue Credibility?
$4.90 for a double bottom. Coming your way.
BAS would you like a shovel and a bucket for your sandbox behavior.. Missling is your FUDster. He is killing this opportunity.
And 2-3 years away.
Who needs FUD when you have Missling. Call IR and send the BOD a message.
No Leadership purchases. No insider purchases. 3rd party review will be in back section of Better Homes and Gardens.
I think even shorts want Missling out.
PW you worked for executives. I worked for share and stake holders.
No results here. I worked with Ichan. Missling ain't what is needed.
PW what was your career? What level did you operate as?
PW Skarpelos brought him in. It would look like his failure too. Which it is. I thought the Science was amazing. I called the shot on Missling in 2018 when we were waiting for results and he came up with BS and precision medicine.
He made us wait for Excellence when he should have NDAed Avatar.
PW he wanted to be a hero with Pediatric rare disease. He FAILED. Do you remember PDD Statistically Significant results 3 years ago. He Failed. If he effs up Alz we are dead in the water.
What do 43 employees do all day if trials are outsourced.
sell this now for whatever we can get. screw his ego. he effed this up.
I agree with you. Some idiots post comments about others and contribute nothing but criticism of other posters. Ef them.
Respectfully frrol, 2-73 isn't nearly finished. Two words. PDD and statistically significant. He has done a miserable job getting 2-73 approved.
He only dropped 3-71 as a distraction not a pivot for his horrible decision making.
We are only keeping Pediatric rare disease and licensing out the rest. RETT is pediatric because he wanted to wait for the voucher. Now he's screwed. Just poor obviously bad choices with choice decision making.
Wednesday call will be 15 minutes long. That includes normal 5 minute late start. Smoke and mirrors and report on expenses rising. Maybe one analyst question. He is unqualified.
Get rid of him. Setting up a SAB is just another way he tries to make it APPEAR that WGT. He's big on APPEARANCES not on substance.
If Missling does not have a positive, great news, cll everyone should call the BOD and rant on them and tell them you will sue them individually along with the company for malfeaceance.
It's early in the month. He just wants to get it over with. I wish Ma would find a Chinese Investor to buy this. There's got to be 300 Million with CNS disease in China. Maybe Cousin Jack has contacts who can make an offer of $375 per share. I doubt any rational person wants to wait on Missling. You know that there will be BS on the 7th.
So if we don't get a 3rd party review by Feb 2025 what happens?
That's not his call
"Biogen also faced criticism because it was initially charging $56,000 per year for the drug. The Cambridge, Massachusetts, company later slashed the price in half, but critics said it was still too expensive for a drug not proven to slow memory and thinking problems."
Missling stated $54,000.If it works I think $40,000 wouldn't be a problem, 10% of $14M (US and EMA) = $1.4 M X $40,000 = $56B divided by 100M shares equals $560pps
Australia. We started there. They funded the trials. Not long ago we looked for Provisional approval from them. Is Missling hiding this information?
As long as we agree Missling isnt.
Don't they know it's rated a strong buy. lol
You have become annoyingly negative lately. I said Missling, not shareholders or the Board. I bet he told BMY some outrageous number to keep them at Bay. Meanwhile WRF is the 3rd party review
I think Missling did not want $14B for 371 He sees Alz and other Dementias as worth more. Science isn't the problem its Missling.
371 isn't apples to apples to Karunah It has a cognitive effect. Try $20B
There is no credibility for the CEO. Tune up your sarcasm. It's all in your head.
WTFAU TO TELL ANYBODY TO STFU?
Everyone is welcome here to post their opinion on this board without being attacked.
Idiots that pump or even debbie downers can't post here. Nobody is better than anyone else.
idiots do.
Than you Jesse
Mike The Leadership sucks. Either he is trying to make something out of nothing or he lied about Avatar and PDD
Mike being a reverse George isn't a good thing.
Speaking with some friends in NY they feel we zhould claw back Missling"s options and terminate him for cause. Cause equals incompetence.
Missing endpoints is a FAIL. I'm not sure whether you've gone off the deep end and weeks and weeks of announcing GREAT NEWS, but now calling the trial more than a FAIL is absolute BS.
What's happening in Austrailia, where is all started and they paid for trials? DUH
Big week coming up Lebby's letter is now old news. Time to perform.
Certain nit wits add nothing except critiquing other posters or protecting the WOF that led us on to where we are at now.. Nowhere.
No intention to argue with you. If you think those answers are worth investing in good on you. I think that's why we are dropping again.
Ya hey Der let's get that $375 per share and go home. You can buy alot of cheese for dose numbers der.
So, at this point, can any shareholder accurately state where we stand with our business?
Rett FUTURE?
Alzheimers Submission to any authority?
Parkinsons Disease Dementia Status?
Parkinsons Disease Status?
371 Status?
Then, answer why Blackrock would invest an additional $36M?
Kinda feel WTF is going on?